India to Hungary: Cisplatin Export Trade Route

The India to Hungary Cisplatin corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $1.4M USD. The route is dominated by NV REMEDIES PRIVATE LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's cisplatin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $105.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with cisplatin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 19.8%, placing it at rank #3 among India's top cisplatin export destinations globally.

On the import side, key buyers of Indian cisplatin in Hungary include UKRPHARMGROUP LLC, E P H K, XXROFXXS AXXLYTXXAL XXRVIXXS HXXGARXXKFTX and 1 others. UKRPHARMGROUP LLC is the single largest importer with 4 shipments valued at $1.3M USD.

India's cisplatin exports to Hungary are driven primarily by a handful of large-scale manufacturers. NV REMEDIES PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Hungary benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — NV REMEDIES PRIVATE LIMITED, VENUS REMEDIES LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $105.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cisplatin concentrate for sol.for infusion 1 mg/ml 50 ml vial(50mg/50ml) 1ml cont. cisplatin 1mg and cisplatin concentrate for solution for infusion 1 mg/ml 100ml/vial (100mg/100ml)1ml contains cisplatin 1mg, suggesting that buyers in Hungary tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, UKRPHARMGROUP LLC is the largest importer with 4 shipments worth $1.3M USD — representing 95% of all cisplatin imports from India on this route.